HIVE Blockchain Technologies Ltd. (NASDAQ:HIVE) Short interest down 26.6% in November
HIVE Blockchain Technologies Ltd. (NASDAQ:HIVE – Get Rating ) saw a large decline in short interest in the month of November. As of November 15, there was short interest on a total of 5,960,000 shares, a decrease of 26.6% from a total of 8,120,000 shares on October 31. Approximately 7.9% of the shares in the company are sold short. Based on an average trading volume of 1,190,000 shares, the days-to-cover ratio is currently 5.0 days.
HIVE Blockchain Technologies Stock Up 5.0%
NASDAQ HIVE opened at $2.11 on Thursday. The company has a debt ratio of 3.75, a quick ratio of 3.75 and a debt ratio of 0.11. HIVE Blockchain Technologies has a one year low of $1.98 and a one year high of $20.25. The stock has a 50-day moving average price of $2.97 and a 200-day moving average price of $3.78.
Wall Street analyst weighs in
Several research firms have weighed in on HIVE. HC Wainwright boosted their price target on HIVE Blockchain Technologies from $6.00 to $7.00 and gave the stock a “buy” rating in a research note on Thursday, August 18th. Canaccord Genuity Group boosted their price target on HIVE Blockchain Technologies from $5.50 to $7.00 and gave the stock a “buy” rating in a research note on Monday, August 29th. Canaccord Genuity Group boosted their price objective on HIVE Blockchain Technologies from $5.50 to $7.00 in a research note on Monday, August 29th. TheStreet downgraded HIVE Blockchain Technologies from a “c” rating to a “d+” rating in a research note on Thursday, September 1st. Finally, StockNews.com upgraded HIVE Blockchain Technologies to a “sell” rating in a research report on Friday, 21st. October.
Institutional Trading of HIVE Blockchain Technologies
Several hedge funds and other institutional investors have recently bought and sold shares in HIVE. State Street Corp purchased a new stake in HIVE Blockchain Technologies during the 2nd quarter valued at $1,007,000. IHT Wealth Management LLC purchased a new stake in HIVE Blockchain Technologies during the 3rd quarter valued at $110,000. BlackRock Inc. raised its stake in HIVE Blockchain Technologies by 25.9% during the 3rd quarter. BlackRock Inc. now owns 82,303 shares of the company’s stock valued at $310,000 after buying an additional 16,951 shares during the period. Toroso Investments LLC raised its stake in HIVE Blockchain Technologies by 132.2% during the 3rd quarter. Toroso Investments LLC now owns 25,291 shares of the company’s stock valued at $95,000 after buying an additional 14,400 shares during the period. Finally, UBS Group AG raised its stake in HIVE Blockchain Technologies by 174.5% in the third quarter. UBS Group AG now owns 17,829 shares of the company’s stock worth $67,000 after purchasing an additional 11,333 shares during the period. Hedge funds and other institutional investors own 8.08% of the company’s shares.
HIVE Blockchain Technologies Company Profile
(Get rating)
HIVE Blockchain Technologies Ltd. operates as a cryptocurrency mining company in Canada, Sweden and Iceland. It mines and sells digital currencies, including Ethereum, Ethereum Classic, and Bitcoin. The company was formerly known as Leeta Gold Corp. and changed its name to HIVE Blockchain Technologies Ltd.
See also
This instant news alert was generated by narrative science technology and financial data from MarketBeat to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial staff prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider HIVE Blockchain Technologies, you want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best-performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and HIVE Blockchain Technologies was not on the list.
While HIVE Blockchain Technologies currently has a “Buy” rating among analysts, top-rated analysts believe that these five stocks are better buys.
See the five stocks here
